No Benefit for MRI-Guided Treat-to-Target Strategy in Rheumatoid Arthritis
A treat-to-target strategy guided by magnetic resonance imaging (MRI) did not improve disease activity or reduce radiographic progression compared with a conventional treat-to-target strategy among patients with rheumatoid arthritis (RA) in clinical remission, according to data published in JAMA. Researchers conducted a 2-year, randomized, multicenter trial (ClinicalTrials.gov identifier: NCT01656278) to determine whether an MRI-guided strategy improves outcomes among patients…
